目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T6962 | Apoptosis MAO Autophagy Monoamine Oxidase | ||
Rasagiline Mesylate (AGN1135) 是一种高效的,不可逆的选择性线粒体单胺氧化酶 (MAO) 抑制剂,抑制大鼠脑 MAO B 和 MAO A 的IC50分别为 4.43 nM 和 412 nM。 | |||
T3534 | Monoamine Transporter | ||
Tetrabenazine Racemate (Rubigen) 是一种选择性和可逆的囊泡单胺转运蛋白 2(VMAT-2) 抑制剂。它阻断神经递质吸收到肾上腺素能储存囊泡中,并已被用作囊泡运输系统的高亲和力标记。 | |||
T5678 | MAO Monoamine Oxidase | ||
Lazabemide hydrochloride (N-(2-Aminoethyl)-5-chlor-2-pyridincarbox) 是一种单胺氧化酶 B 的选择性的可逆抑制剂,但对 MAO-A 活性较低。它在高浓度时,具有抑制单胺摄取的作用,抑制去甲肾上腺素、血清素和多巴胺摄取。它可用于研究帕金森和阿尔茨海默病。 | |||
T4274 | Dopamine Receptor 5-HT Receptor | ||
Melitracen hydrochloride (Thymeol hydrochloride) 是一种可口服的双相抗抑郁药和抗焦虑药。它可以通过突触前膜抑制去甲肾上腺素和5-羟色胺(5-HT)的吸收,从而诱导突触空间中单胺递质的增加。 | |||
T6352 | NMDAR iGluR | ||
(-)-Dizocilpine maleate ((-)-MK 801 (Maleate)) 是一种选择性且非竞争性的 N-甲基-D-天冬氨酸 (NMDA) 受体拮抗剂,Ki 为 211.7 nM。它是一种 Dizocilpine 的活性较低的 (-)-对映体,具有抗抑郁作用。 | |||
T5887 | MAO Monoamine Oxidase | ||
7-Hydroxy-3,4-dihydro-2(1H)-quinolinone 是弱MAO-A 抑制剂,IC50=183 μM,对 MAO-B 无作用。 | |||
T4024 | DNA Endogenous Metabolite Monoamine Oxidase | ||
Norharmane (β-Carboline) 是一种有效的选择性单胺氧化酶 A (MAO-A) 抑制剂,Ki=3.34 μM。 | |||
T6S0923 | Apoptosis Antiviral Influenza Virus Tyrosine Kinases Antibacterial PKC | ||
Hypericin (Cyclosan) 是贯叶连翘的提取物,有抗菌、抗病毒、抗肿瘤和抗抑郁作用。 | |||
T7563 | Monoamine Transporter | ||
NBI-98782 ((+)-α-DHTBZ) 是一种囊泡单胺转运蛋白 (VMAT2) 抑制剂,Ki 为0.97nM。 | |||
T0006 | Guanylate cyclase Microtubule Associated NO Synthase Parasite Monoamine Oxidase | ||
Methylene Blue trihydrate (Basic blue 9) 是鸟苷酸环化酶,单胺氧化酶 A 和 NO 合酶抑制剂。它是血管加压药,在医疗中通常用作染料。它具有抗伤害感受,抗疟疾,抗抑郁和抗焦虑作用,可用于高铁血红蛋白血症,神经退行性疾病和异环磷酰胺引起的脑病的研究。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPJ-00379 | AOC3 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells | ||
Membrane primary amine oxidase(AOC3), also known as vascular adhesion protein (VAP-1) and HPAO, this protein is a member of the semicarbazide-sensitive amine oxidase (SSAO) family. VAP-1 is a type 1 membrane-bound glycoprotein that has a distal adhesion domain and an enzymatically active amine oxidase site outside of the membrane, VAP-1 has adhesive properties, functional monoamine oxidase activity, and possibly plays a role in glucose handling, leukocyte trafficking, and migration during inflammation. This rise in metabolic products contributes to generating advanced glycation end-products and oxidative stress along with the monoamine detoxification in the organism. It is highly expressed on the endothelium of the lung and trachea, and absent from leukocytes and epithelial cells. Membrane-bound VAP-1 releases an active, soluble form of the protein, which may be conducive to increased inflammation and the progression of many vascular disorders. In particular, elevation of VAP-1 activity and the increased enzymatic-mediated deamination is proposed to play a role in renal and vascular disease, oxidative stress, acute and chronic hyperglycemia, and diabetes complications.
|
|||||
TMPY-03056 | LSD1 Protein, Human, Recombinant (His & GST) | Human | Baculovirus Insect Cells | ||
LSD1 belongs to the flavin monoamine oxidase family. It contains 1 SWIRM domain and is a component of an RCOR/GFI/LSD1/HDAC complex. LSD1 interacts directly with GFI1 and GFI1B. LSD1 specifically removes histone H3K4me2 to H3K4me1 or H3K4me0 through a FAD-dependent oxidative reaction. When forming a complex with an androgen receptor (and possibly other nuclear hormone receptors), LSD1 changes its substrates to H3K9me2. Thus LSD1 is considered to act as a coactivator or a corepressor. It may play a role in the repression of neuronal genes. Alone, LSD1 is unable to demethylate H3 'Lys-4' on nucleosomes and requires the presence of RCOR1/CoREST to achieve such activity.
|